MK-5684 与替代 NHA 在 mCRPC 中的研究 (MK-5684-003) (OMAHA-003)
在既往接受过新一代激素药物 (NHA) 和紫杉烷化疗的转移性去势抵抗性前列腺癌 (mCRPC) 受试者中进行 MK-5684 与替代性醋酸阿比特龙或恩杂鲁胺的 3 期随机、开放标签研究
This is a phase 3, randomized, open-label study of opevesostat compared to alternative abiraterone acetate or enzalutamide in participants with metastatic castration-resistant prostate cancer (mCRPC) with respect to overall survival (OS) in participants with mCRPC previously treated with next-generation hormonal agent (NHA) and taxane-based chemotherapy. It is hypothesized that opevesostat is superior with respect to OS in androgen receptor ligand binding domain (AR LBD) mutation-negative and -positive participants.
研究概览
地位
条件
研究类型
注册 (估计的)
阶段
- 第三阶段
联系人和位置
学习联系方式
- 姓名:Toll Free Number
- 电话号码:1-888-577-8839
- 邮箱:Trialsites@msd.com
学习地点
-
-
Anhui
-
Hefei、Anhui、中国、230000
- 招聘中
- Second Affiliated hospital of Anhui Medical University-Urology ( Site 0408)
-
接触:
- Study Coordinator
- 电话号码:+86 02782201756
-
-
Beijing Municipality
-
Beijing、Beijing Municipality、中国、100034
- 招聘中
- Peking University First Hospital-Urology ( Site 0390)
-
接触:
- Study Coordinator
- 电话号码:+86 (010) 64008229
-
Beijing、Beijing Municipality、中国、100050
- 招聘中
- Beijing Friendship Hospital Affiliate of Capital University ( Site 0396)
-
接触:
- Study Coordinator
- 电话号码:+86(010)63138375
-
Beijing、Beijing Municipality、中国、100142
- 招聘中
- Beijing Cancer hospital-Urinary Surgery ( Site 0395)
-
接触:
- Study Coordinator
- 电话号码:86 010 8812 1122
-
-
Chongqing Municipality
-
Chongqing、Chongqing Municipality、中国、400030
- 招聘中
- Chongqing University Cancer Hospital ( Site 0416)
-
接触:
- Study Coordinator
- 电话号码:02365075629
-
Chongqing、Chongqing Municipality、中国、400038
- 招聘中
- Southwest Hospital of Third Military Medical University ( Site 0420)
-
接触:
- Study Coordinator
- 电话号码:023 68765878
-
Chongqing、Chongqing Municipality、中国、404100
- 招聘中
- Chongqing Three Gorges Central Hospital's ( Site 0426)
-
接触:
- Study Coordinator
- 电话号码:023 58103150
-
Chongqing、Chongqing Municipality、中国、400010
- 招聘中
- The First Affiliated Hospital of Chongqing Medical University ( Site 0427)
-
接触:
- Study Coordinator
- 电话号码:023 89012012
-
-
Fujian
-
Fuzhou、Fujian、中国、350005
- 招聘中
- The First Affiliated Hospital Of Fujian Medical University-Urology ( Site 0414)
-
接触:
- Study Coordinator
- 电话号码:+86059187983333
-
Xiamen、Fujian、中国、361003
- 招聘中
- The First Affiliated hospital of Xiamen University-Urology ( Site 0415)
-
接触:
- Study Coordinator
- 电话号码:0592-2132222
-
-
Guangdong
-
Guangzhou、Guangdong、中国、511400
- 招聘中
- Sun Yat-sen University Cancer Center-Internal medicine ( Site 0413)
-
接触:
- Study Coordinator
- 电话号码:+8602087343533
-
Guangzhou、Guangdong、中国、510230
- 招聘中
- The First Affiliated Hospital of Guangzhou Medical University ( Site 0412)
-
接触:
- Study Coordinator
- 电话号码:+8602034294311
-
-
Hubei
-
Wuhan、Hubei、中国、430079
- 招聘中
- Hubei Cancer Hospital-Urinary surgery ( Site 0406)
-
接触:
- Study Coordinator
- 电话号码:8613907110640
-
Wuhan、Hubei、中国、430000
- 招聘中
- Tongji Hospital Tongji Medical,Science & Technology ( Site 0407)
-
接触:
- Study Coordinator
- 电话号码:027-83665555
-
-
Hunan
-
Changsha、Hunan、中国、410013
- 招聘中
- Hunan Cancer Hospital ( Site 0405)
-
接触:
- Study Coordinator
- 电话号码:073189762270
-
-
Jiangsu
-
Huaian、Jiangsu、中国、223300
- 招聘中
- First Huai'an Hospital Affiliated to Nanjing Medical University ( Site 0436)
-
接触:
- Study Coordinator
- 电话号码:0517-80872519
-
Nanjing、Jiangsu、中国、210008
- 招聘中
- Nanjing Drum Tower Hospital The Affiliated Hospital of Nanjing University Medical School-Urology ( Site 0377)
-
接触:
- Study Coordinator
- 电话号码:025-83105910
-
Wuxi、Jiangsu、中国、214122
- 招聘中
- Affiliated hospital of Jiangnan university ( Site 0434)
-
接触:
- Study Coordinator
- 电话号码:0510-88682957
-
-
Jiangxi
-
Nanchang、Jiangxi、中国、330029
- 招聘中
- Jiangxi Cancer Hospital ( Site 0386)
-
接触:
- Study Coordinator
- 电话号码:86079188317256
-
-
Shaanxi
-
Xi'an、Shaanxi、中国、710061
- 招聘中
- The First Affiliated Hospital of Xi'an Jiaotong University-Oncology ( Site 0393)
-
接触:
- Study Coordinator
- 电话号码:029-85323112
-
Xi'an、Shaanxi、中国、710004
- 招聘中
- The Second Affiliated Hospital of Xi'an Jiaotong University ( Site 0394)
-
接触:
- Study Coordinator
- 电话号码:029-87679000
-
-
Shandong
-
Yantai、Shandong、中国、264099
- 招聘中
- Yantai Yuhuangding Hospital ( Site 0397)
-
接触:
- Study Coordinator
- 电话号码:86 0535 6691999
-
-
Shanghai Municipality
-
Shanghai、Shanghai Municipality、中国、200000
- 招聘中
- Fudan University Shanghai Cancer Center-Urology department ( Site 0376)
-
接触:
- Study Coordinator
- 电话号码:021-38196379
-
Shanghai、Shanghai Municipality、中国、200041
- 招聘中
- Huadong Hospital Affiliated to Fudan University-Urology ( Site 0388)
-
接触:
- Study Coordinator
- 电话号码:021-62483180
-
Shanghai、Shanghai Municipality、中国、200032
- 招聘中
- Zhongshan Hospital Fudan University ( Site 0430)
-
接触:
- Study Coordinator
- 电话号码:021-31587858
-
-
Sichuan
-
Chengdu、Sichuan、中国、500643
- 招聘中
- The Third People's Hospital of Chengdu (CDTPH) ( Site 0428)
-
接触:
- Study Coordinator
- 电话号码:67566947
-
Chengdu、Sichuan、中国、610041
- 招聘中
- West China Hospital, Sichuan University-Urology Surgery ( Site 0417)
-
接触:
- Study Coordinator
- 电话号码:+86028-85422114
-
Nanchong、Sichuan、中国、500643
- 招聘中
- Nanchong Central Hospital-urology ( Site 0422)
-
接触:
- Study Coordinator
- 电话号码:08172606822
-
Suining、Sichuan、中国、629000
- 招聘中
- Suining Central Hospital ( Site 0437)
-
接触:
- Study Coordinator
- 电话号码:08252292093
-
-
Tianjin Municipality
-
Tianjin、Tianjin Municipality、中国、300060
- 招聘中
- Tianjin Medical University Cancer Institute & Hospital ( Site 0392)
-
接触:
- Study Coordinator
- 电话号码:+862223340123
-
Tianjin、Tianjin Municipality、中国、300211
- 招聘中
- The Second Hospital of Tianjin Medical University ( Site 0391)
-
接触:
- Study Coordinator
- 电话号码:+8602288326748
-
-
Xinjiang
-
Ürümqi、Xinjiang、中国、830000
- 招聘中
- Xinjiang Medical University Cancer Hospital - Urumqi-Urology ( Site 0419)
-
接触:
- Study Coordinator
- 电话号码:86 09917819156
-
-
Yunnan
-
Kunming、Yunnan、中国、650033
- 招聘中
- The Second Affiliated Hospital Of Kunming Medical University ( Site 0429)
-
接触:
- Study Coordinator
- 电话号码:087165351281
-
Kunming、Yunnan、中国、650107
- 招聘中
- Yunnan Province Cancer Hospital ( Site 0418)
-
接触:
- Study Coordinator
- 电话号码:0871-68179210
-
-
Zhejiang
-
Hangzhou、Zhejiang、中国、310014
- 招聘中
- Zhejiang Provincial People's Hospital-Urology ( Site 0378)
-
接触:
- Study Coordinator
- 电话号码:+86 13858019285
-
Hangzhou、Zhejiang、中国、310022
- 招聘中
- Zhejiang Cancer Hospital ( Site 0435)
-
接触:
- Study Coordinator
- 电话号码:0571-88122261
-
Jiaxing、Zhejiang、中国、314001
- 招聘中
- The First Hospital of Jiaxing-urology ( Site 0380)
-
接触:
- Study Coordinator
- 电话号码:+86 13957391616
-
Ningbo、Zhejiang、中国、315010
- 招聘中
- The First Affiliated Hospital of Ningbo University ( Site 0383)
-
接触:
- Study Coordinator
- 电话号码:86057487085588
-
Wenzhou、Zhejiang、中国、325000
- 招聘中
- The First Affiliated Hospital of Wenzhou Medical University-Urology Surgery ( Site 0379)
-
接触:
- Study Coordinator
- 电话号码:+8618267857001
-
-
-
-
Capital Region
-
Copenhagen、Capital Region、丹麦、2100
- 招聘中
- Rigshospitalet ( Site 0576)
-
接触:
- Study Coordinator
- 电话号码:+45 35453545
-
-
Region Syddanmark
-
Odense、Region Syddanmark、丹麦、5000
- 主动,不招人
- Odense Universitetshospital-Department of oncology ( Site 0579)
-
Vejle、Region Syddanmark、丹麦、7100
- 招聘中
- Vejle Sygehus ( Site 0578)
-
接触:
- Study Coordinator
- 电话号码:+45 79405000
-
-
-
-
-
Afula、以色列、1834111
- 招聘中
- Emek Medical Center ( Site 0830)
-
接触:
- Study Coordinator
- 电话号码:0546708579
-
Haifa、以色列、3109601
- 招聘中
- Rambam Health Care Campus-Oncology Division ( Site 0826)
-
接触:
- Study Coordinator
- 电话号码:04-7776234
-
Jerusalem、以色列、9112001
- 招聘中
- Hadassah Medical Center ( Site 0833)
-
接触:
- Study Coordinator
- 电话号码:02-6777111
-
Kfar Saba、以色列、4428164
- 招聘中
- Meir Medical Center. ( Site 0832)
-
接触:
- Study Coordinator
- 电话号码:0503745684
-
Petah Tikva、以色列、4941492
- 招聘中
- Rabin Medical Center ( Site 0828)
-
接触:
- Study Coordinator
- 电话号码:972-50-3745684
-
Ramat Gan、以色列、5265601
- 招聘中
- Sheba Medical Center ( Site 0827)
-
接触:
- Study Coordinator
- 电话号码:: +972-35302191
-
-
-
-
Alberta
-
Edmonton、Alberta、加拿大、T6G 1Z2
- 招聘中
- Cross Cancer Institute ( Site 0332)
-
接触:
- Study Coordinator
- 电话号码:7804328762
-
-
Ontario
-
Ottawa、Ontario、加拿大、K1H 8L6
- 招聘中
- The Ottawa Hospital - General Campus-The Ottawa Hospital Cancer Centre ( Site 0336)
-
接触:
- Study Coordinator
- 电话号码:613-737-7700
-
Toronto、Ontario、加拿大、M4N 3M5
- 招聘中
- Sunnybrook Research Institute ( Site 0331)
-
接触:
- Study Coordinator
- 电话号码:647-533-1023
-
Toronto、Ontario、加拿大、M5G 2M9
- 招聘中
- Princess Margaret Cancer Centre ( Site 0330)
-
接触:
- Study Coordinator
- 电话号码:(416) 946-4501
-
-
Quebec
-
Greenfield Park、Quebec、加拿大、J4V 2H1
- 招聘中
- Centre Intégré de Santé et de Services Sociaux de la Montérégie-Centre ( Site 0328)
-
接触:
- Study Coordinator
- 电话号码:4504665000 ext 3226
-
Montreal、Quebec、加拿大、H2X 3E4
- 主动,不招人
- Centre Hospitalier de l'Université de Montréal ( Site 0326)
-
Québec、Quebec、加拿大、G1J 1Z4
- 招聘中
- Centre intégré de cancérologie du CHU de Québec Université Laval, Hôpital de l'Enfant-Jésus ( Site 0327)
-
接触:
- Study Coordinator
- 电话号码:418 525-4444
-
Sherbrooke、Quebec、加拿大、J1H 5H4
- 主动,不招人
- Centre intégré universitaire de santé et de services sociaux de l'Estrie - Centre Hospitalier Univer ( Site 0329)
-
-
-
-
-
Debrecen、匈牙利、4032
- 招聘中
- Debreceni Egyetem Klinikai Kozpont-Onkológiai Klinika ( Site 0758)
-
接触:
- Study Coordinator
- 电话号码:+3652411717
-
-
Bács-Kiskun county
-
Kecskemét、Bács-Kiskun county、匈牙利、6000
- 招聘中
- Bacs-Kiskun Varmegyei Oktatokorhaz-Onkoradiologiai Kozpont ( Site 0752)
-
接触:
- Study Coordinator
- 电话号码:+3676516719
-
-
Nógrád megye
-
Salgótarján、Nógrád megye、匈牙利、3100
- 招聘中
- Nograd Varmegyei Szent Lazar Korhaz-Onkologia es Sugarterapias Osztaly ( Site 0761)
-
接触:
- Study Coordinator
- 电话号码:+3632522000
-
-
Pest County
-
Budapest、Pest County、匈牙利、1122
- 招聘中
- Országos Onkológiai Intézet-Urogenitális Tumorok és Klinikai Farmakológiai Osztály ( Site 0756)
-
接触:
- Study Coordinator
- 电话号码:+36122486001171
-
-
-
-
-
Taichung、台湾、40447
- 招聘中
- China Medical University Hospital-Department of Urology ( Site 1503)
-
接触:
- Study Coordinator
- 电话号码:+886-4-2205-2121
-
Tainan、台湾、704
- 招聘中
- National Cheng Kung University Hospital-Urology ( Site 1502)
-
接触:
- Study Coordinator
- 电话号码:+886-6-2353535
-
Taipei、台湾、112
- 招聘中
- Taipei Veterans General Hospital ( Site 1505)
-
接触:
- Study Coordinator
- 电话号码:+886-2-28712121
-
Taipei、台湾、10002
- 招聘中
- National Taiwan University Hospital-Urology ( Site 1506)
-
接触:
- Study Coordinator
- 电话号码:+886-2-2312-3456
-
Taoyuan、台湾、333
- 招聘中
- Chang Gung Medical Foundation-Linkou Branch-Medical Oncology ( Site 1504)
-
接触:
- Study Coordinator
- 电话号码:+886-3-3281200
-
-
-
-
Bogota D.C.
-
Bogotá、Bogota D.C.、哥伦比亚、111321
- 招聘中
- Clinica Colsanitas S.A, Sede Clínica Universitaria Colombia-Center Investigator ( Site 0501)
-
接触:
- Study Coordinator
- 电话号码:6017058333
-
-
Cesar Department
-
Valledupar、Cesar Department、哥伦比亚、200001
- 招聘中
- Sociedad De Oncología y Hematología Del Cesar SAS-Oncology ( Site 0502)
-
接触:
- Study Coordinator
- 电话号码:+57 3158505190
-
-
Departamento de Córdoba
-
Montería、Departamento de Córdoba、哥伦比亚、230002
- 招聘中
- IMAT S.A.S ( Site 0504)
-
接触:
- Study Coordinator
- 电话号码:+573135342052
-
-
Santander Department
-
Piedecuesta、Santander Department、哥伦比亚、681017
- 招聘中
- Fundación Cardiovascular de Colombia ( Site 0503)
-
接触:
- Study Coordinator
- 电话号码:+573203400438
-
-
Valle del Cauca Department
-
Cali、Valle del Cauca Department、哥伦比亚、760032
- 招聘中
- Fundación Valle del Lili ( Site 0505)
-
接触:
- Study Coordinator
- 电话号码:+573133288646
-
Cali、Valle del Cauca Department、哥伦比亚、760042
- 完全的
- Clínica Imbanaco S.A.S ( Site 0509)
-
-
-
-
-
Adana、土耳其(türkiye)、01250
- 招聘中
- Baskent University Dr. Turgut Noyan Research and Training Center-ONCOLOGY ( Site 1554)
-
接触:
- Study Coordinator
- 电话号码:+903223444444
-
Ankara、土耳其(türkiye)、06010
- 招聘中
- Gulhane Egitim Arastirma Hastanesi ( Site 1558)
-
接触:
- Study Coordinator
- 电话号码:00903123042020
-
Ankara、土耳其(türkiye)、06230
- 招聘中
- Hacettepe Universite Hastaneleri-oncology hospital ( Site 1551)
-
接触:
- Study Coordinator
- 电话号码:+90 (312) 305 29 41
-
Ankara、土耳其(türkiye)、06520
- 招聘中
- Memorial Ankara Hastanesi-Medical Oncology ( Site 1557)
-
接触:
- Study Coordinator
- 电话号码:903122536666
-
Ankara、土耳其(türkiye)、06800
- 招聘中
- Ankara Bilkent Şehir Hastanesi-Medical Oncology ( Site 1552)
-
接触:
- Study Coordinator
- 电话号码:00903125526060
-
Istanbul、土耳其(türkiye)、34668
- 招聘中
- Istanbul Universitesi Cerrahpasa-Medical Oncology ( Site 1555)
-
接触:
- Study Coordinator
- 电话号码:0090212 414 30 00
-
Istanbul、土耳其(türkiye)、34722
- 招聘中
- TC Saglik Bakanligi Goztepe Prof. Dr. Suleyman Yalcin Sehir Hastanesi-oncology ( Site 1553)
-
接触:
- Study Coordinator
- 电话号码:+902166065200
-
Istanbul、土耳其(türkiye)、34010
- 招聘中
- Koc Universitesi Hastanesi ( Site 1561)
-
接触:
- Study Coordinator
- 电话号码:+908502508250
-
Samsun、土耳其(türkiye)、55200
- 招聘中
- Samsun Medical Park Hastanesi-medical oncology ( Site 1560)
-
接触:
- Study Coordinator
- 电话号码:+90 (539) 780 90 07
-
-
-
-
Jalisco
-
Guadalajara、Jalisco、墨西哥、44630
- 招聘中
- CIO - Centro de Inmuno-Oncología de Occidente ( Site 1103)
-
接触:
- Study Coordinator
- 电话号码:+52 3313587270
-
-
Mexico City
-
Mexico City、Mexico City、墨西哥、14308
- 招聘中
- Quemex Medical and Research ( Site 1112)
-
接触:
- Study Coordinator
- 电话号码:+52555673461
-
Mexico City、Mexico City、墨西哥、68020
- 招聘中
- Centro de Investigacion Clinica de Oaxaca ( Site 1109)
-
接触:
- Study Coordinator
- 电话号码:+529515473137
-
-
Nuevo León
-
Monterrey、Nuevo León、墨西哥、64460
- 招聘中
- Filios Alta Medicina ( Site 1106)
-
接触:
- Study Coordinator
- 电话号码:+528110623583
-
Monterrey、Nuevo León、墨西哥、64460
- 招聘中
- Hospital Universitario "Dr. Jose Eleuterio Gonzalez"-Servicio de Oncología ( Site 1107)
-
接触:
- Study Coordinator
- 电话号码:+528183338111 Ext.9
-
-
Yucatán
-
Mérida、Yucatán、墨西哥、97070
- 完全的
- Medical Care and Research SA de CV ( Site 1108)
-
-
-
-
Styria
-
Graz、Styria、奥地利、8036
- 招聘中
- Medizinische Universität Graz-Innere Medizin Klin. Abt. Onkologie ( Site 0280)
-
接触:
- Study Coordinator
- 电话号码:+4331638581307
-
-
Upper Austria
-
Linz、Upper Austria、奥地利、4020
- 招聘中
- Ordensklinikum Linz GmbH Elisabethinen-Urologie ( Site 0276)
-
接触:
- Study Coordinator
- 电话号码:+4373276774724
-
Wels、Upper Austria、奥地利、4600
- 招聘中
- Klinikum Wels-Grieskirchen GmbH ( Site 0279)
-
接触:
- Study Coordinator
- 电话号码:+4372424152328
-
-
-
-
Espírito Santo
-
Vitória、Espírito Santo、巴西、29041-295
- 招聘中
- Hospital Santa Rita de Cassia-Centro de Pesquisa Clínica ( Site 0320)
-
接触:
- Study Coordinator
- 电话号码:+55 27 3334-8346
-
-
Estado de Bahia
-
Salvador、Estado de Bahia、巴西、41680-430
- 招聘中
- Obras Sociais Irma Dulce ( Site 0302)
-
接触:
- Study Coordinator
- 电话号码:+55 71 3310-1978
-
-
Minas Gerais
-
Belo Horizonte、Minas Gerais、巴西、30110-934
- 招聘中
- Hospital Felicio Rocho ( Site 0317)
-
接触:
- Study Coordinator
- 电话号码:+55 31 35147195
-
Belo Horizonte、Minas Gerais、巴西、30380-472
- 招聘中
- Hospital Mario Penna ( Site 0309)
-
接触:
- Study Coordinator
- 电话号码:+551 31 3299-9543
-
-
Paraná
-
Curitiba、Paraná、巴西、80440-220
- 招聘中
- Hospital Universitário Evangélico Mackenzie-Centro de Oncologia Mackenzie ( Site 0314)
-
接触:
- Study Coordinator
- 电话号码:5541991681411
-
-
Santa Catarina
-
Itajaí、Santa Catarina、巴西、88301-220
- 招聘中
- Clínica de Neoplasias Litoral ( Site 0305)
-
接触:
- Study Coordinator
- 电话号码:+5547984046243
-
-
São Paulo
-
Bragança Paulista、São Paulo、巴西、12916-542
- 招聘中
- Hospital Universitário São Francisco de Assis - Bragança Paulista ( Site 0308)
-
接触:
- Study Coordinator
- 电话号码:+55 11 98337-1381
-
São Paulo、São Paulo、巴西、01509-010
- 主动,不招人
- A. C. Camargo Cancer Center ( Site 0310)
-
-
-
-
-
Berlin、德国、10117
- 招聘中
- Charité Universitaetsmedizin Berlin - Campus Mitte ( Site 0679)
-
接触:
- Study Coordinator
- 电话号码:0049 30 450615285
-
Hamburg、德国、20246
- 招聘中
- Universitaetsklinikum Hamburg-Eppendorf-Onkologisches Zentrum ( Site 0705)
-
接触:
- Study Coordinator
- 电话号码:+4915222815585
-
-
Bavaria
-
Munich、Bavaria、德国、81675
- 主动,不招人
- klinikum rechts der isar der technischen universität münchen-Urologische Klinik und Poliklinik ( Site 0696)
-
-
Mecklenburg-Vorpommern
-
Schwerin、Mecklenburg-Vorpommern、德国、19055
- 招聘中
- HELIOS Kliniken Schwerin ( Site 0694)
-
接触:
- Study Coordinator
- 电话号码:+493855202120
-
-
North Rhine-Westphalia
-
Bonn、North Rhine-Westphalia、德国、53127
- 招聘中
- Universitätsklinikum Bonn-Klinik und Poliklinik für Urologie und Kinderurologie ( Site 0680)
-
接触:
- Study Coordinator
- 电话号码:+4922828714249
-
Münster、North Rhine-Westphalia、德国、48149
- 招聘中
- Universitätsklinikum Münster - Albert Schweitzer Campus-Klinik für Urologie ( Site 0678)
-
接触:
- Study Coordinator
- 电话号码:0049251-8344658
-
-
Schleswig-Holstein
-
Lübeck、Schleswig-Holstein、德国、23538
- 招聘中
- Universitätsklinikum Schleswig-Holstein-Klinik für Urologie ( Site 0691)
-
接触:
- Study Coordinator
- 电话号码:+4945150043699
-
-
Thuringia
-
Jena、Thuringia、德国、07747
- 招聘中
- Universitätsklinikum Jena-Klinik und Poliklinik für Urologie ( Site 0682)
-
接触:
- Study Coordinator
- 电话号码:+49 3641 9 32 9947
-
-
-
-
-
Milan、意大利、20132
- 招聘中
- Ospedale San Raffaele-Oncologia Medica ( Site 0876)
-
接触:
- Study Coordinator
- 电话号码:+390226435668
-
-
Emilia-Romagna
-
Meldola、Emilia-Romagna、意大利、47014
- 招聘中
- IRCCS - Istituto Romagnolo per lo Studio dei Tumori (IRST) "Dino Amadori"-Oncologia Medica ( Site 0879)
-
接触:
- Study Coordinator
- 电话号码:+390543739100
-
-
Lombardy
-
Milan、Lombardy、意大利、20133
- 招聘中
- Fondazione IRCCS Istituto Nazionale dei Tumori-Struttura Complessa Oncologia Medica 1 ( Site 0877)
-
接触:
- Study Coordinator
- 电话号码:00390223903033
-
-
-
-
Akershus
-
Lørenskog、Akershus、挪威、1474
- 招聘中
- Akershus Universitetssykehus-Onkologisk avdeling ( Site 1227)
-
接触:
- Study Coordinator
- 电话号码:+4767963800
-
-
Sor-Trondelag
-
Trondheim、Sor-Trondelag、挪威、7030
- 主动,不招人
- St. Olavs Hospital-Kreftklinikken ( Site 1231)
-
-
Østfold fylke
-
Sarpsborg、Østfold fylke、挪威、1714
- 完全的
- Sykehuset Østfold Kalnes ( Site 1228)
-
-
-
-
-
Prague、捷克语、150 06
- 主动,不招人
- Fakultní nemocnice Motol a Homolka ( Site 0551)
-
-
Brno-mesto
-
Brno、Brno-mesto、捷克语、656 53
- 招聘中
- Masarykuv onkologicky ustav-Klinika komplexni onkologicke pece ( Site 0553)
-
接触:
- Study Coordinator
- 电话号码:+420 543 136 216
-
-
Moravian-Silesian Region
-
Ostrava、Moravian-Silesian Region、捷克语、708 52
- 招聘中
- Fakultni nemocnice Ostrava-Klinika onkologicka ( Site 0554)
-
接触:
- Study Coordinator
- 电话号码:+420597372264
-
-
Olomouc Region
-
Olomouc、Olomouc Region、捷克语、779 00
- 招聘中
- Fakultni nemocnice Olomouc-Onkologicka klinika ( Site 0555)
-
接触:
- Study Coordinator
- 电话号码:+420 588 444 699
-
-
-
-
Central Singapore
-
Singapore、Central Singapore、新加坡、168583
- 招聘中
- National Cancer Centre Singapore ( Site 1377)
-
接触:
- Study Coordinator
- 电话号码:+65-64368000
-
Singapore、Central Singapore、新加坡、308433
- 招聘中
- Tan Tock Seng Hospital-Medical Oncology ( Site 1378)
-
接触:
- Study Coordinator
- 电话号码:+65-62566011
-
Singapore、Central Singapore、新加坡、119074
- 招聘中
- National University Hospital ( Site 1376)
-
接触:
- Study Coordinator
- 电话号码:6569082222
-
-
-
-
Bay of Plenty
-
Tauranga、Bay of Plenty、新西兰、3112
- 招聘中
- Tauranga Hospital-Bay of Plenty Clinical Trials Unit ( Site 1201)
-
接触:
- Study Coordinator
- 电话号码:+64277033845
-
-
Otago
-
Dunedin、Otago、新西兰、9016
- 招聘中
- Dunedin Hospital-Southern Blood and Cancers Service ( Site 1203)
-
接触:
- Study Coordinator
- 电话号码:+64 3 470 9692
-
-
-
-
-
Akita、日本、010-8543
- 招聘中
- Akita University Hospital ( Site 0904)
-
接触:
- Study Coordinator
- 电话号码:+81188341111
-
Fukuoka、日本、812-8582
- 招聘中
- Kyushu University Hospital ( Site 0919)
-
接触:
- Study Coordinator
- 电话号码:+81926411151
-
Fukushima、日本、960-1295
- 招聘中
- Fukushima Medical University Hospital ( Site 0933)
-
接触:
- Study Coordinator
- 电话号码:+81245471111
-
Gifu、日本、501-1112
- 招聘中
- Gifu University Hospital ( Site 0910)
-
接触:
- Study Coordinator
- 电话号码:+81-58-230-6000
-
Hiroshima、日本、734-8551
- 招聘中
- Hiroshima University Hospital ( Site 0916)
-
接触:
- Study Coordinator
- 电话号码:+81-82-257-5555
-
Kagoshima、日本、890-8520
- 招聘中
- Kagoshima University Hospital ( Site 0929)
-
接触:
- Study Coordinator
- 电话号码:+81-99-275-5111
-
Kumamoto、日本、860-0008
- 招聘中
- National Hospital Organization Kumamoto Medical Center ( Site 0924)
-
接触:
- Study Coordinator
- 电话号码:+81963536501
-
Miyazaki、日本、880-8510
- 招聘中
- Miyazaki Prefectural Miyazaki Hospital ( Site 0927)
-
接触:
- Study Coordinator
- 电话号码:+81985244181
-
Miyazaki、日本、889-1692
- 招聘中
- University of Miyazaki Hospital ( Site 0926)
-
接触:
- Study Coordinator
- 电话号码:+81-98-585-1510
-
Nagano、日本、381-8551
- 招聘中
- Nagano Municipal Hospital ( Site 0932)
-
接触:
- Study Coordinator
- 电话号码:+81-26-295-1199
-
Ōita、日本、870-0263
- 招聘中
- National Hospital Organization Oita Medical Center ( Site 0925)
-
接触:
- Study Coordinator
- 电话号码:+81-97-593-1111
-
-
Chiba
-
Sakura、Chiba、日本、285-8741
- 招聘中
- Toho University Sakura Medical Center ( Site 0906)
-
接触:
- Study Coordinator
- 电话号码:+81434628811
-
-
Ehime
-
Tōon、Ehime、日本、791-0295
- 招聘中
- Ehime University Hospital ( Site 0918)
-
接触:
- Study Coordinator
- 电话号码:+81-89-964-5111
-
-
Fukuoka
-
Kitakyushu、Fukuoka、日本、807-8556
- 完全的
- Hospital of the University of Occupational and Environmental Health, Japan ( Site 0921)
-
Kurume、Fukuoka、日本、830-0011
- 招聘中
- Kurume University Hospital ( Site 0920)
-
接触:
- Study Coordinator
- 电话号码:+81-942-35-3311
-
-
Hokkaido
-
Asahikawa、Hokkaido、日本、078-8510
- 招聘中
- Asahikawa Medical University Hospital ( Site 0901)
-
接触:
- Study Coordinator
- 电话号码:+81-166-65-2111
-
Sapporo、Hokkaido、日本、060-8543
- 招聘中
- Sapporo Medical University Hospital ( Site 0902)
-
接触:
- Study Coordinator
- 电话号码:+81-11-611-2111
-
Sapporo、Hokkaido、日本、060-8648
- 招聘中
- Hokkaido University Hospital ( Site 0931)
-
接触:
- Study Coordinator
- 电话号码:+81117161161
-
-
Hyōgo
-
Kobe、Hyōgo、日本、650-0017
- 招聘中
- Kobe University Hospital ( Site 0914)
-
接触:
- Study Coordinator
- 电话号码:+81783825111
-
-
Ishikawa-ken
-
Mukai-awagasaki、Ishikawa-ken、日本、920-0265
- 招聘中
- Kanazawa Medical University Hospital ( Site 0909)
-
接触:
- Study Coordinator
- 电话号码:+81-76-286-3511
-
-
Kagawa-ken
-
Kita、Kagawa-ken、日本、761-0701
- 招聘中
- Kagawa University Hospital ( Site 0917)
-
接触:
- Study Coordinator
- 电话号码:+81878985111
-
-
Kanagawa
-
Yokohama、Kanagawa、日本、232-0024
- 招聘中
- Yokohama City University Medical Center ( Site 0908)
-
接触:
- Study Coordinator
- 电话号码:+81452615656
-
-
Nagasaki
-
Ōmura、Nagasaki、日本、856-8562
- 招聘中
- National Hospital Organization Nagasaki Medical Center ( Site 0923)
-
接触:
- Study Coordinator
- 电话号码:+81-957-52-3121
-
-
Nara
-
Kashihara、Nara、日本、634-8522
- 完全的
- Nara Medical University Hospital ( Site 0915)
-
-
Okinawa
-
Shimajiri、Okinawa、日本、901-0417
- 招聘中
- Nanbu Tokushukai Hospital ( Site 0930)
-
接触:
- Study Coordinator
- 电话号码:+81-98-998-3221
-
-
Osaka
-
Hirakata、Osaka、日本、573-1191
- 招聘中
- Kansai Medical University Hospital ( Site 0912)
-
接触:
- Study Coordinator
- 电话号码:+81-72-804-0101
-
Sakai、Osaka、日本、599-8247
- 招聘中
- Bell Land General Hospital ( Site 0913)
-
接触:
- Study Coordinator
- 电话号码:+81722342001
-
Suita、Osaka、日本、565-0871
- 招聘中
- The University of Osaka Hospital ( Site 0911)
-
接触:
- Study Coordinator
- 电话号码:+81668795111
-
-
Saga-ken
-
Saga、Saga-ken、日本、840-8571
- 招聘中
- Saga-Ken Medical Centre Koseikan ( Site 0922)
-
接触:
- Study Coordinator
- 电话号码:+81952242171
-
-
Tokyo
-
Minato、Tokyo、日本、105-8471
- 完全的
- The Jikei University Hospital ( Site 0907)
-
-
-
-
-
Antofagasta、智利、1240000
- 招聘中
- Bradford Hill Norte ( Site 0357)
-
接触:
- Study Coordinator
- 电话号码:56442023631
-
-
Coquimbo Region
-
La Serena、Coquimbo Region、智利、1720430
- 完全的
- IC La Serena Research ( Site 0356)
-
-
Los Ríos Region
-
Valdivia、Los Ríos Region、智利、5110683
- 主动,不招人
- Clinical Research Chile SpA ( Site 0358)
-
-
Maule Region
-
Talca、Maule Region、智利、3465584
- 招聘中
- Clinica Universidad Catolica del Maule-Oncology ( Site 0355)
-
接触:
- Study Coordinator
- 电话号码:+56947532700
-
-
Region M. de Santiago
-
Santiago、Region M. de Santiago、智利、8330024
- 招聘中
- Pontificia Universidad Catolica de Chile-Hemato-Oncology ( Site 0354)
-
接触:
- Study Coordinator
- 电话号码:+56934331806
-
Santiago、Region M. de Santiago、智利、8420383
- 招聘中
- Bradfordhill-Clinical Area ( Site 0351)
-
接触:
- Study Coordinator
- 电话号码:+56229490970
-
Santiago、Region M. de Santiago、智利、7500921
- 主动,不招人
- Fundación Arturo López Pérez ( Site 0353)
-
-
-
-
-
Paris、法国、75015
- 主动,不招人
- Hôpital Européen Georges Pompidou ( Site 0628)
-
-
Ain
-
Lille、Ain、法国、59020
- 招聘中
- Centre Oscar Lambret ( Site 0634)
-
接触:
- Study Coordinator
- 电话号码:+33320295959
-
-
Bas-Rhin
-
Strasbourg、Bas-Rhin、法国、67200
- 招聘中
- Hopitaux Universitaires de Strasbourg ( Site 0627)
-
接触:
- Study Coordinator
- 电话号码:+33368767207
-
-
Gard
-
Nîmes、Gard、法国、30029
- 招聘中
- Centre Hospitalier Universitaire de Nîmes - Institut de Cancérologie du Gard - Hôpital Universitaire ( Site 0630)
-
接触:
- Study Coordinator
- 电话号码:+33466683301
-
-
Ille-et-Vilaine
-
Rennes、Ille-et-Vilaine、法国、35042
- 招聘中
- Centre Eugène Marquis Rennes - Centre de Lutte Contre le Cancer ( Site 0632)
-
接触:
- Study Coordinator
- 电话号码:+33299253182
-
-
Puy-de-Dome
-
Clermont-Ferrand、Puy-de-Dome、法国、63003
- 招聘中
- Centre Jean Perrin - Centre Régional de Lutte contre le Cancer d'Auvergne ( Site 0629)
-
接触:
- Study Coordinator
- 电话号码:+33473278005
-
-
Pyrenees-Atlantiques
-
Bayonne、Pyrenees-Atlantiques、法国、64109
- 招聘中
- Centre Hospitalier de la Cote Basque ( Site 0633)
-
接触:
- Study Coordinator
- 电话号码:33559443535
-
-
Val-de-Marne
-
Villejuif、Val-de-Marne、法国、94800
- 招聘中
- Gustave Roussy ( Site 0626)
-
接触:
- Study Coordinator
- 电话号码:+33 1 42 11 42 11
-
-
-
-
Kuyavian-Pomeranian Voivodeship
-
Bydgoszcz、Kuyavian-Pomeranian Voivodeship、波兰、85-796
- 主动,不招人
- Centrum Onkologii im. Prof. Franciszka Lukaszczyka ( Site 1302)
-
Grudziądz、Kuyavian-Pomeranian Voivodeship、波兰、86-300
- 完全的
- Regionalny Szpital Specjalistyczny im. dr. Władyslawa Biegańskiego ( Site 1316)
-
Torun、Kuyavian-Pomeranian Voivodeship、波兰、87-100
- 完全的
- Wojewodzki Szpital Zespolony im Ludwika Rydygiera w Toruniu ( Site 1304)
-
-
Masovian Voivodeship
-
Siedlce、Masovian Voivodeship、波兰、08-110
- 招聘中
- Mazowiecki Szpital Wojewódzki w Siedlcach-Siedleckie Centrum Onkologii ( Site 1310)
-
接触:
- Study Coordinator
- 电话号码:+48256403301
-
-
West Pomeranian Voivodeship
-
Koszalin、West Pomeranian Voivodeship、波兰、75-581
- 招聘中
- Szpital Wojewódzki im. Mikoaja Kopernika w Koszalinie-Oddzial Dzienny Chemioterapii ( Site 1303)
-
接触:
- Study Coordinator
- 电话号码:+48943488930
-
Szczecin、West Pomeranian Voivodeship、波兰、71-730
- 招聘中
- Zachodniopomorskie Centrum Onkologii ( Site 1311)
-
接触:
- Study Coordinator
- 电话号码:+48914251502
-
-
Świętokrzyskie Voivodeship
-
Kielce、Świętokrzyskie Voivodeship、波兰、25-734
- 招聘中
- Swietokrzyskie Centrum Onkologii, Samodzielny Publiczny Zakl-Klinika Onkologii Klinicznej, Dzial Ch ( Site 1318)
-
接触:
- Study Coordinator
- 电话号码:+48413674811
-
-
-
-
-
Hato Rey、波多黎各、00917
- 完全的
- Puerto Rico Medical Research Center LLC ( Site 1354)
-
Ponce、波多黎各、00717
- 主动,不招人
- Ad-Vance Medical Research-Research ( Site 1353)
-
San Juan、波多黎各、00909
- 完全的
- Pan American Center for Oncology Trials - Ciudadela ( Site 1351)
-
-
-
-
Bangkok
-
Bangkok、Bangkok、泰国、10330
- 招聘中
- Chulalongkorn University ( Site 1530)
-
接触:
- Study Coordinator
- 电话号码:+6622564533
-
Bangkoknoi、Bangkok、泰国、10700
- 招聘中
- Faculty of Medicine Siriraj Hospital ( Site 1531)
-
接触:
- Study Coordinator
- 电话号码:+6624194489
-
-
Changwat Khon Kaen
-
Muang、Changwat Khon Kaen、泰国、40002
- 招聘中
- Faculty of Medicine - Khon Kaen University ( Site 1526)
-
接触:
- Study Coordinator
- 电话号码:+66 43 366568-9
-
-
Changwat Songkhla
-
Hat Yai、Changwat Songkhla、泰国、90110
- 招聘中
- Songklanagarind hospital ( Site 1527)
-
接触:
- Study Coordinator
- 电话号码:+6674451469
-
-
-
-
New South Wales
-
Dubbo、New South Wales、澳大利亚、2830
- 招聘中
- Dubbo Hospital ( Site 0235)
-
接触:
- Study Coordinator
- 电话号码:0268096200
-
Macquarie University、New South Wales、澳大利亚、2109
- 招聘中
- Macquarie University-MQ Health Clinical Trials Unit ( Site 0234)
-
接触:
- Study Coordinator
- 电话号码:0298122979
-
Westmead、New South Wales、澳大利亚、2145
- 招聘中
- Westmead Hospital ( Site 0232)
-
接触:
- Study Coordinator
- 电话号码:+61288905555
-
-
Queensland
-
Brisbane、Queensland、澳大利亚、4102
- 招聘中
- Princess Alexandra Hospital-Cancer Care Serices ( Site 0237)
-
接触:
- Study Coordinator
- 电话号码:+6173176 9289
-
-
Victoria
-
Melbourne、Victoria、澳大利亚、3000
- 招聘中
- Peter MacCallum Cancer Centre-Parkville Cancer Clinical Trials Unit (PCCTU) ( Site 0230)
-
接触:
- Study Coordinator
- 电话号码:03 8559 5000
-
-
-
-
-
Dublin、爱尔兰、D24 NR0A
- 招聘中
- Tallaght University Hospital ( Site 0801)
-
接触:
- Study Coordinator
- 电话号码:+35314144299
-
-
Dublin
-
Dublin、Dublin、爱尔兰、D04 T6F4
- 招聘中
- St. Vincent's University Hospital ( Site 0802)
-
接触:
- Study Coordinator
- 电话号码:+35312214000
-
-
-
-
Stockholm County
-
Stockholm、Stockholm County、瑞典、171 64
- 主动,不招人
- Karolinska Universitetssjukhuset Solna ( Site 1478)
-
-
Uppsala County
-
Uppsala、Uppsala County、瑞典、751 85
- 招聘中
- Akademiska sjukhuset-Blod- och tumörsjukdomar ( Site 1477)
-
接触:
- Study Coordinator
- 电话号码:0046186110000
-
-
Västra Götaland County
-
Gothenburg、Västra Götaland County、瑞典、413 45
- 招聘中
- Sahlgrenska Universitetssjukhuset ( Site 1479)
-
接触:
- Study Coordinator
- 电话号码:0046313421000
-
-
-
-
-
Lima、秘鲁、15038
- 招聘中
- INSTITUTO NACIONAL DE ENFERMEDADES NEOPLASICAS-Medical Oncology ( Site 1256)
-
接触:
- Study Coordinator
- 电话号码:+511 2016500
-
Lima、秘鲁、15036
- 主动,不招人
- Aliada-Oncologìa ( Site 1257)
-
Lima、秘鲁、15036
- 主动,不招人
- IPOR Instituto Peruano de Oncología & Radioterapia-Centro de Investigación ( Site 1254)
-
Lima、秘鲁、15036
- 主动,不招人
- Oncosalud-Clinical Research ( Site 1260)
-
-
Departamento de Junín
-
Concepción、Departamento de Junín、秘鲁、12125
- 招聘中
- Instituto Regional de Enfermedades Neoplasicas del Centro (IREN CENTRO) ( Site 1258)
-
接触:
- Study Coordinator
- 电话号码:+51 958864658
-
-
La Libertad
-
Trujillo、La Libertad、秘鲁、13009
- 招聘中
- Clínica Sánchez Ferrer ( Site 1261)
-
接触:
- Study Coordinator
- 电话号码:948319999
-
-
-
-
California
-
Orange、California、美国、92868
- 完全的
- University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0040)
-
Palo Alto、California、美国、94304
- 招聘中
- Stanford Cancer Center ( Site 0036)
-
接触:
- Study Coordinator
- 电话号码:650-725-2078
-
Riverside、California、美国、92505
- 招聘中
- Kaiser Permanente Riverside Medical Center ( Site 0099)
-
接触:
- Study Coordinator
- 电话号码:951-809-8361
-
-
Colorado
-
Aurora、Colorado、美国、80045
- 招聘中
- Anschutz Cancer Pavilion ( Site 0046)
-
接触:
- Study Coordinator
- 电话号码:302-290-3598
-
Highlands Ranch、Colorado、美国、80129
- 招聘中
- University of Colorado Health - Highlands Ranch Hospital ( Site 0111)
-
接触:
- Study Coordinator
- 电话号码:302-290-3598
-
Lakewood、Colorado、美国、80228
- 完全的
- Colorado Clinical Research ( Site 0067)
-
Lone Tree、Colorado、美国、80124
- 招聘中
- University of Colorado Health - Lone Tree Medical Center ( Site 0112)
-
接触:
- Study Coordinator
- 电话号码:720-848-5146
-
-
Connecticut
-
New Haven、Connecticut、美国、06510
- 招聘中
- Yale-New Haven Hospital-Yale Cancer Center ( Site 0064)
-
接触:
- Study Coordinator
- 电话号码:203-737-8076
-
-
Florida
-
Fort Myers、Florida、美国、33901
- 完全的
- Florida Cancer Specialists - South ( Site 7003)
-
Miami、Florida、美国、33136
- 招聘中
- University of Miami Hospital and Clinics, Sylvester Cancer Center ( Site 0051)
-
接触:
- Study Coordinator
- 电话号码:305-243-1543
-
Miami、Florida、美国、33125
- 完全的
- Bruce W. Carter Veterans Affairs Medical Center ( Site 0082)
-
-
Illinois
-
Chicago、Illinois、美国、60637
- 招聘中
- University of Chicago Medical Center ( Site 0045)
-
接触:
- Study Coordinator
- 电话号码:773-702-7609
-
Chicago、Illinois、美国、60612
- 招聘中
- University of Illinois at Chicago ( Site 0105)
-
接触:
- Study Coordinator
- 电话号码:973-330-2391
-
-
Iowa
-
Iowa City、Iowa、美国、52242
- 完全的
- University of Iowa ( Site 0047)
-
-
Kentucky
-
Lexington、Kentucky、美国、40536
- 完全的
- University of Kentucky Chandler Medical Center ( Site 0048)
-
-
Louisiana
-
New Orleans、Louisiana、美国、70121
- 完全的
- Ochsner Clinic Foundation ( Site 0108)
-
-
Maryland
-
Baltimore、Maryland、美国、21201
- 招聘中
- Baltimore Veterans Affairs Medical Center ( Site 0069)
-
接触:
- Study Coordinator
- 电话号码:410-707-4011
-
Baltimore、Maryland、美国、21201
- 招聘中
- Greenebaum Comprehensive Cancer Center ( Site 0049)
-
接触:
- Study Coordinator
- 电话号码:410-707-4011
-
-
Michigan
-
Detroit、Michigan、美国、48202
- 完全的
- Henry Ford Hospital ( Site 0015)
-
-
Minnesota
-
Marshall、Minnesota、美国、56258
- 招聘中
- Avera Cancer Institute - Marshall ( Site 0122)
-
接触:
- Study Coordinator
- 电话号码:605-601-1830
-
Minneapolis、Minnesota、美国、55455
- 招聘中
- M Health Fairview Clinics and Surgery Center ( Site 0019)
-
接触:
- Study Coordinator
- 电话号码:612-626-1422
-
Saint Louis Park、Minnesota、美国、55416
- 主动,不招人
- Metro-Minnesota Community Clinical Oncology ( Site 0014)
-
-
Mississippi
-
Hattiesburg、Mississippi、美国、39401
- 招聘中
- Hattiesburg Clinic Hematology/Oncology ( Site 0120)
-
接触:
- Study Coordinator
- 电话号码:601-261-1700
-
-
Missouri
-
St Louis、Missouri、美国、63110
- 招聘中
- Washington University School of Medicine-Internal Medicine/Oncology ( Site 0062)
-
接触:
- Study Coordinator
- 电话号码:314-286-2341
-
-
Nebraska
-
Omaha、Nebraska、美国、68105
- 招聘中
- University Of Nebraska Medical Center-Oncology/Hematology ( Site 0095)
-
接触:
- Study Coordinator
- 电话号码:402-559-8500
-
-
Nevada
-
Las Vegas、Nevada、美国、89148
- 招聘中
- Comprehensive Cancer Centers of Nevada ( Site 0010)
-
接触:
- Study Coordinator
- 电话号码:702-952-1251
-
-
New Jersey
-
Morristown、New Jersey、美国、07960
- 招聘中
- Atlantic Health System Morristown Medical Center ( Site 0115)
-
接触:
- Study Coordinator
- 电话号码:973-971-7960
-
New Brunswick、New Jersey、美国、08903
- 完全的
- Rutgers Cancer Institute of New Jersey ( Site 0033)
-
-
New York
-
The Bronx、New York、美国、10468
- 招聘中
- James J. Peters VA Medical Center ( Site 0088)
-
接触:
- Study Coordinator
- 电话号码:718-584-9000
-
-
Ohio
-
Cleveland、Ohio、美国、44106
- 招聘中
- University Hospitals Cleveland Medical Center ( Site 0043)
-
接触:
- Study Coordinator
- 电话号码:216-844-3951
-
-
Oregon
-
Portland、Oregon、美国、97239
- 招聘中
- VA Portland Health Care System ( Site 0058)
-
接触:
- Study Coordinator
- 电话号码:503-220-8262
-
Portland、Oregon、美国、97239
- 完全的
- Oregon Health and Science University ( Site 0028)
-
-
Pennsylvania
-
Pittsburgh、Pennsylvania、美国、15212
- 完全的
- AHN Allegheny General Hospital ( Site 0001)
-
-
South Carolina
-
Charleston、South Carolina、美国、29401
- 完全的
- Ralph H. Johnson VA Health Care System (RHJVAHCS)-Urology ( Site 0083)
-
-
South Dakota
-
Aberdeen、South Dakota、美国、57401
- 招聘中
- Avera Cancer Institute - Aberdeen ( Site 0123)
-
接触:
- Study Coordinator
- 电话号码:605-601-1830
-
Mitchell、South Dakota、美国、57301
- 招聘中
- Avera Cancer Institute - Mitchell ( Site 0121)
-
接触:
- Study Coordinator
- 电话号码:605-601-1830
-
Pierre、South Dakota、美国、57501
- 招聘中
- Avera Cancer Institute - Pierre ( Site 0118)
-
接触:
- Study Coordinator
- 电话号码:605-224-3370
-
Sioux Falls、South Dakota、美国、57105
- 招聘中
- Avera Cancer Institute- Research ( Site 0094)
-
接触:
- Study Coordinator
- 电话号码:605-322-6900
-
Yankton、South Dakota、美国、57078
- 招聘中
- Avera Cancer Institute - Yankton ( Site 0117)
-
接触:
- Study Coordinator
- 电话号码:605-655-1800
-
-
Tennessee
-
Nashville、Tennessee、美国、37203
- 招聘中
- SCRI Oncology Partners ( Site 7000)
-
接触:
- Study Coordinator
- 电话号码:615-218-4647
-
-
Texas
-
Austin、Texas、美国、78731
- 招聘中
- Texas Oncology - Central/South Texas ( Site 8003)
-
接触:
- Study Coordinator
- 电话号码:512-427-9400
-
Dallas、Texas、美国、75246
- 完全的
- Texas Oncology - DFW ( Site 8001)
-
Houston、Texas、美国、77024
- 招聘中
- Texas Oncology - Gulf Coast ( Site 8002)
-
接触:
- Study Coordinator
- 电话号码:713-467-1722
-
-
Virginia
-
Charlottesville、Virginia、美国、22908
- 招聘中
- University of Virginia Health System ( Site 0054)
-
接触:
- Study Coordinator
- 电话号码:434-327-3029
-
Richmond、Virginia、美国、23219
- 完全的
- VCU Health Adult Outpatient Pavillion ( Site 0061)
-
Roanoke、Virginia、美国、24014
- 招聘中
- Blue Ridge Cancer Care ( Site 0004)
-
接触:
- Study Coordinator
- 电话号码:540-982-0237
-
-
Washington
-
Seattle、Washington、美国、98109
- 招聘中
- Fred Hutchinson Cancer Center ( Site 0013)
-
接触:
- Study Coordinator
- 电话号码:617-413-9079
-
-
Wisconsin
-
Milwaukee、Wisconsin、美国、53226
- 招聘中
- Medical College of Wisconsin ( Site 0020)
-
接触:
- Study Coordinator
- 电话号码:414-805-4600
-
-
-
-
Northern Savonia
-
Kuopio、Northern Savonia、芬兰、70200
- 主动,不招人
- Kuopion Yliopistollinen Sairaala ( Site 0603)
-
-
Pirkanmaa
-
Tampere、Pirkanmaa、芬兰、33520
- 招聘中
- Tampereen yliopistollinen sairaala ( Site 0604)
-
接触:
- Study Coordinator
- 电话号码:358331166811
-
-
Southwest Finland
-
Turku、Southwest Finland、芬兰、20520
- 招聘中
- Turku University Hospital-Department of Oncology ( Site 0601)
-
接触:
- Study Coordinator
- 电话号码:35823130729
-
-
-
-
-
Manchester、英国、m20 4bx
- 招聘中
- The Christie NHS Foundation Trust ( Site 1608)
-
接触:
- Study Coordinator
- 电话号码:+441614463000
-
-
Cambridgeshire
-
Cambridge、Cambridgeshire、英国、CB2 2QQ
- 招聘中
- Addenbrooke's Hospital ( Site 1605)
-
接触:
- Study Coordinator
- 电话号码:01223216083
-
-
England
-
Truro、England、英国、TR1 3LJ
- 招聘中
- The Royal Cornwall Hospital ( Site 1610)
-
接触:
- Study Coordinator
- 电话号码:01872258345
-
-
Glasgow City
-
Glasgow、Glasgow City、英国、G12 0YN
- 招聘中
- The Beatson West of Scotland Cancer Centre ( Site 1603)
-
接触:
- Study Coordinator
- 电话号码:+441413017000
-
-
Hammersmith and Fulham
-
London、Hammersmith and Fulham、英国、W6 8RF
- 招聘中
- Charing Cross Hospital-Oncology Research ( Site 1606)
-
接触:
- Study Coordinator
- 电话号码:0208 331 10277
-
-
London, City of
-
London、London, City of、英国、NW1 2PG
- 招聘中
- University College London Hospital ( Site 1612)
-
接触:
- Study Coordinator
- 电话号码:0203 447 3042
-
-
-
-
Gelderland
-
Nijmegen、Gelderland、荷兰、6525 GA
- 招聘中
- Radboudumc-Medical Oncology ( Site 1152)
-
接触:
- Study Coordinator
- 电话号码:+31 (0)24 361 0353
-
-
Limburg
-
Sittard-Geleen、Limburg、荷兰、6162 BG
- 招聘中
- Zuyderland Medical Centre-Trialbureau Interne Geneeskunde ( Site 1163)
-
接触:
- Study Coordinator
- 电话号码:+31884599740
-
Venlo、Limburg、荷兰、5912 BL
- 完全的
- VieCuri Medisch Centrum ( Site 1173)
-
-
North Brabant
-
Tilburg、North Brabant、荷兰、5022 GC
- 招聘中
- ETZ Elisabeth-Internal Medicine ( Site 1160)
-
接触:
- Study Coordinator
- 电话号码:+3113221 0210
-
-
North Holland
-
Amsterdam、North Holland、荷兰、1066 CX
- 招聘中
- Nederlands Kanker Instituut - Antoni van Leeuwenhoek - NKI-AVL ( Site 1153)
-
接触:
- Study Coordinator
- 电话号码:+31205122569
-
Amsterdam、North Holland、荷兰、1081 HV
- 完全的
- Amsterdam UMC, locatie VUmc ( Site 1156)
-
Hoofddorp、North Holland、荷兰、2134 TM
- 主动,不招人
- Spaarne Gasthuis - Hoofddorp-Oncology ( Site 1170)
-
-
Provincie Friesland
-
Leeuwarden、Provincie Friesland、荷兰、8934 AD
- 主动,不招人
- Medische Centrum Leeuwarden ( Site 1172)
-
-
South Holland
-
Schiedam、South Holland、荷兰、3118 JH
- 招聘中
- Franciscus Gasthuis & Vlietland, Locatie Vlietland ( Site 1151)
-
接触:
- Study Coordinator
- 电话号码:003110- 4617590
-
The Hague、South Holland、荷兰、2545 AA
- 招聘中
- Haga Ziekenhuis locatie Leyweg-Oncology ( Site 1164)
-
接触:
- Study Coordinator
- 电话号码:+31702102143
-
-
Utrecht
-
Amersfoort、Utrecht、荷兰、3813 TZ
- 招聘中
- Meander Medisch Centrum ( Site 1157)
-
接触:
- Study Coordinator
- 电话号码:+003133 - 850 1189
-
-
-
-
-
Lugo、西班牙、27003
- 招聘中
- Hospital Lucus Augusti-Oncology ( Site 1432)
-
接触:
- Study Coordinator
- 电话号码:+34982296459
-
Seville、西班牙、41013
- 招聘中
- HOSPITAL UNIVERSITARIO VIRGEN DEL ROCIO-Medical Oncology ( Site 1428)
-
接触:
- Study Coordinator
- 电话号码:34955013068
-
-
Cadiz
-
Jerez de la Frontera、Cadiz、西班牙、11407
- 招聘中
- Hospital Jerez de la Frontera ( Site 1427)
-
接触:
- Study Coordinator
- 电话号码:+34661753582
-
-
Madrid, Comunidad de
-
Madrid、Madrid, Comunidad de、西班牙、28034
- 招聘中
- Hospital Universitario Ramón y Cajal-Medical Oncology ( Site 1431)
-
接触:
- Study Coordinator
- 电话号码:34913368263
-
Madrid、Madrid, Comunidad de、西班牙、28041
- 招聘中
- Hospital Universitario 12 de Octubre-Medical Oncology ( Site 1433)
-
接触:
- Study Coordinator
- 电话号码:608464547
-
-
Orense
-
Ourense、Orense、西班牙、32005
- 招聘中
- Complexo Hospitalario Universitario de Ourense ( Site 1426)
-
接触:
- Study Coordinator
- 电话号码:+34988385471
-
-
Valenciana, Comunitat
-
Valencia、Valenciana, Comunitat、西班牙、46009
- 招聘中
- Fundación Instituto Valenciano de Oncología-Oncologico ( Site 1430)
-
接触:
- Study Coordinator
- 电话号码:+34 961114229
-
-
-
-
-
Buenos Aires、阿根廷、C1118AAT
- 主动,不招人
- Hospital Aleman-Oncology ( Site 0207)
-
Mendoza、阿根廷、M5500AYB
- 招聘中
- Fundacion Centro Oncologico de Integración Regional-Medical Oncology ( Site 0204)
-
接触:
- Study Coordinator
- 电话号码:+5492615449901
-
-
Buenos Aires
-
Ciudad Autónoma de Buenos Aires、Buenos Aires、阿根廷、C1280AEB
- 主动,不招人
- Hospital Británico de Buenos Aires-Oncology ( Site 0202)
-
Mar del Plata、Buenos Aires、阿根廷、B7600FZO
- 主动,不招人
- Instituto de Investigaciones Clínicas Mar del Plata ( Site 0201)
-
-
Buenos Aires F.D.
-
Buenos Aires、Buenos Aires F.D.、阿根廷、C1419AHN
- 招聘中
- Asociación de Beneficencia Hospital Sirio Libanés ( Site 0205)
-
接触:
- Study Coordinator
- 电话号码:+5491145744343
-
Buenos Aires、Buenos Aires F.D.、阿根廷、C1426ANZ
- 招聘中
- Instituto Alexander Fleming-Alexander Fleming ( Site 0206)
-
接触:
- Study Coordinator
- 电话号码:+5491132218900
-
-
Santa Fe Province
-
Rosario、Santa Fe Province、阿根廷、S2000DSV
- 招聘中
- Sanatorio Parque ( Site 0208)
-
接触:
- Study Coordinator
- 电话号码:+5493414200222
-
-
-
-
-
Seoul、韩国、06351
- 招聘中
- Samsung Medical Center ( Site 1405)
-
接触:
- Study Coordinator
- 电话号码:+82234101767
-
Seoul、韩国、03080
- 招聘中
- Seoul National University Hospital-Oncology ( Site 1401)
-
接触:
- Study Coordinator
- 电话号码:+82220721672
-
Seoul、韩国、03722
- 招聘中
- Severance Hospital, Yonsei University Health System-Medical oncology ( Site 1404)
-
接触:
- Study Coordinator
- 电话号码:+82222288138
-
-
Seoul
-
Songpagu、Seoul、韩国、05505
- 招聘中
- Asan Medical Center-Oncology ( Site 1402)
-
接触:
- Study Coordinator
- 电话号码:+82230106095
-
-
-
-
-
Hong Kong、香港
- 主动,不招人
- Queen Mary Hospital ( Site 0727)
-
Shatin、香港
- 主动,不招人
- Prince of Wales Hospital ( Site 0730)
-
-
-
-
-
Kuala Lumpur、马来西亚、50586
- 招聘中
- Hospital Kuala Lumpur-Radiotherapy and Oncology ( Site 1078)
-
接触:
- Study Coordinator
- 电话号码:+60326155810
-
-
Johor
-
Johor Bahru、Johor、马来西亚、81100
- 招聘中
- Hospital Sultan Ismail ( Site 1081)
-
接触:
- Study Coordinator
- 电话号码:+6073565155
-
-
Kuala Lumpur
-
Lembah Pantai、Kuala Lumpur、马来西亚、59100
- 完全的
- University Malaya Medical Centre ( Site 1077)
-
-
Putrajaya
-
Putrajaya、Putrajaya、马来西亚、62250
- 招聘中
- National Cancer Institute ( Site 1079)
-
接触:
- Study Coordinator
- 电话号码:+60388925418
-
-
Sarawak
-
Kuching、Sarawak、马来西亚、93586
- 招聘中
- Sarawak General Hospital-Radiotherapy Unit ( Site 1076)
-
接触:
- Study Coordinator
- 电话号码:+6082276820
-
-
参与标准
资格标准
适合学习的年龄
接受健康志愿者
有资格学习的性别
描述
Inclusion Criteria:
- Has histologically- or cytologically-confirmed adenocarcinoma of the prostate without small cell histology.
- Has prostate cancer progression while on androgen deprivation therapy (or post bilateral orchiectomy) within 6 months before Screening
- Has current evidence of distant metastatic disease (M1 disease) documented by either bone lesions on bone scan and/or soft tissue disease by computed tomography/magnetic resonance imaging (CT/MRI).
- Has disease that progressed during or after treatment with 1 novel hormonal agent (NHA)
- Has received 1 but no more than 2 taxane-based chemotherapy regimens for metastatic castration-resistant prostate cancer (mCRPC) and has had progressive disease (PD) during or after treatment
- Has ongoing androgen deprivation with serum testosterone <50 ng/dL (<1.7 nM)
- Has provided tumor tissue from a fresh core or excisional biopsy from soft tissue not previously irradiated
- Has an Eastern Cooperative Oncology Group (ECOG) performance status of 0 or 1 assessed within 7 days of randomization
- Has had prior treatment with PARPi or were deemed ineligible to receive treatment by the investigator or have refused PARPi treatment
- Has received prior 177Lu-PSMA-617 or were deemed ineligible to receive 177Lu-PSMA-617 treatment by the investigator or refused 177Lu-PSMA-617 treatment
- Participants who have not received cabazitaxel can be enrolled if they are ineligible for cabazitaxel treatment as determined by the investigator or have refused treatment
- If participant received first generation anti-androgen therapy before screening, the participant has evidence of disease progression >4 weeks since the last flutamide treatment and >6 weeks since the last bicalutamide or nilutamide treatment
- Participants receiving bone resorptive therapy (including, but not limited to, bisphosphonate or denosumab) must have been on stable doses for ≥ 4 weeks before the date of randomization
- Participants with human immunodeficiency virus (HIV) infection must have well controlled HIV on antiretroviral therapy (ART)
- Participants who are hepatitis B surface antigen (HBsAg) positive are eligible if they have received hepatitis B virus (HBV) antiviral therapy for at least 4 weeks and have undetectable HBV viral load before randomization
- Participants with history of hepatitis C virus (HCV) infection are eligible if HCV viral load is undetectable at Screening.
- Participants who can produce sperm must agree to the following during the study treatment period and for at least 7 days after the last dose of opevesostat, for at least 30 days after the last dose of abiraterone acetate, and for at least 3 months after the last dose of enzalutamide: EITHER be abstinent OR must agree to use male condom
Exclusion Criteria:
- Has a gastrointestinal disorder that might affect absorption
- Has a history of pituitary dysfunction
- Has poorly controlled diabetes mellitus
- Has clinically significant abnormal serum potassium or sodium level
- Has a history of active or unstable cardio/cerebro-vascular disease, including thromboembolic events
- Has a history of seizure within 6 months of providing documented informed consent or any condition that may predispose to seizures within 12 months before the date of randomization
- Has a history of clinically significant ventricular arrhythmias
- Has received an anticancer monoclonal antibody (mAb) within 4 weeks before the date of randomization, or has not recovered from adverse events (AEs) due to mAbs administered more than 4 weeks before the date of randomization
- Has undergone major surgery, including local prostate intervention (except prostate biopsy), within 28 days before the date of randomization, and has not recovered from the toxicities and/or complications
- Participants who have not adequately recovered from major surgery or have ongoing surgical complications
- Has used herbal or medicinal products that may have hormonal anti-prostate cancer activity and/or are known to decrease prostate-specific Antigen (PSA) (eg, saw palmetto, megesterol acetate, citrus pectin polysaccharide) within 4 weeks before the date of randomization
- Has received radium-223 or Lutetium-177 within 4 weeks before the date of randomization, or has not recovered to Grade ≤1 or baseline from AEs due to radium-223 or Lutetium-177 administered more than 4 weeks before the date of randomization
- Has received treatment with 5-αreductase inhibitors (eg, finasteride or dutasteride), estrogens, or cyproterone within 4 weeks before the date of randomization
- Has received colony-stimulating factors within 28 days before the date of randomization
- Has received a whole blood transfusion in the last 120 days before the date of randomization. Packed red blood cells and platelet transfusions are acceptable if not given within 28 days of the date of randomization
- Has received prior targeted small molecule therapy or NHA treatment within 4 weeks before the first dose of study intervention as follows: enzalutamide or apalutamide within 3 weeks or abiraterone acetate + prednisone or darolutamide within 2 weeks
- Has a "superscan" bone scan
- Has a diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy or any other form of immunosuppressive therapy within 7 days prior the first dose of study medication
- Has a known additional malignancy that is progressing or has required active treatment within the past 3 years
- Has known active central nervous system (CNS) metastases and/or carcinomatous meningitis
- Has an active autoimmune disease that has required systemic treatment in past 2 years
- Has an active infection requiring systemic therapy
- Has concurrent active HBV or known active HCV infection
- Has a history of long QTc syndrome
- Has any of the following at Screening Visit: hypotension (systolic BP <110 mm Hg) or uncontrolled hypertension (systolic BP ≥160 mm Hg or diastolic BP ≥90 mm Hg, in 2 out of 3 recordings with optimized antihypertensive therapy)
- Is unable to swallow capsules/tablets
- Is currently being treated with cytochrome 450-inducing antiepileptic drugs for seizures
- Participants on an unstable dose of thyroid hormone therapy within 6 months before the start of the study intervention
- Received prior systemic anticancer therapy including investigational agents within 4 weeks before the first dose of study intervention
- Received prior radiotherapy within 2 weeks of start of study intervention, or radiation-related toxicities, requiring corticosteroids
- Received a live or live-attenuated vaccine within 30 days before the first dose of study intervention
- Systemic use of the following medications within 2 weeks before the first dose of study intervention: strong CYP3A4 inducers (eg, avasimibe, carbamazepine, lumacaftor, phenobarbital, rifampicin, rifapentine, or St John's Wort); P-gp inhibitors (eg, erythromycin, clarithromycin, rifampicin, ketoconazole, itraconazole, posaconazole, artesunate-pyronaridine, ritonavir, indinavir, nelfinavir, atazanavir, glecaprevir-pibrentasvir, simeprevir, ledipasvir-sofosbuvir, verapamil, diltiazem, dronedarone, propafenone, quinidine, cyclosporine, valspodar, or milk thistle [Silybum marianum])
- Use of aldosterone antagonist (eg, spironolactone, eplerenone) and phenytoin within 4 weeks before the start of the study intervention
学习计划
研究是如何设计的?
设计细节
- 主要用途:治疗
- 分配:随机化
- 介入模型:并行分配
- 屏蔽:无(打开标签)
武器和干预
参与者组/臂 |
干预/治疗 |
|---|---|
|
实验性的:Opevesostat
Participants receive opevesostat 5 mg by oral tablets twice daily (bid) plus dexamethasone 1.5 mg by oral tablets once daily (qd) and 0.1 mg fludrocortisone acetate by oral tablet qd until progression. Hydrocortisone 100 mg (oral or intramuscular [IM]) dose will also be provided to participants for use as rescue medication. Prior to study protocol amendment 9, prednisone was provided as a rescue medication during adrenal recovery, titrated at 5mg daily maintenance dose and then titrated to discontinuation. |
Administered orally
其他名称:
Administered orally or IM as a rescue medication Administered orally Administered orally as a rescue medication Administered orally as rescue medication |
|
有源比较器:Abiraterone Acetate or Enzalutamide
Participants receive abiraterone 1000 mg qd by oral tablets plus prednisone 5 mg bid by oral tablets or enzalutamide 160 mg qd by oral tablets. |
Administered orally as a rescue medication Administered orally
其他名称:
Administered orally
其他名称:
|
研究衡量的是什么?
主要结果指标
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Overall Survival (OS) in Androgen Receptor Ligand Binding Domain (AR LBD) Mutation-Positive Participants
大体时间:Up to ~54 months
|
OS is defined as time from randomization to death due to any cause. OS in AR LBD mutation-positive participants will be reported for each study arm. |
Up to ~54 months
|
|
OS in AR LBD Mutation-Negative Participants
大体时间:Up to ~54 months
|
OS is defined as time from randomization to death due to any cause. OS in AR LBD mutation-negative participants will be reported for each study arm. |
Up to ~54 months
|
次要结果测量
结果测量 |
措施说明 |
大体时间 |
|---|---|---|
|
Radiographic Progression-free Survival (rPFS) Per Prostate Cancer Working Group-modified Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) as Assessed by Blinded Independent Central Review in AR LBD Mutation-Positive Participants
大体时间:Up to ~36 months
|
rPFS is defined as the time from randomization to the first documented disease progression per Prostate Cancer Working Group (PCWG)-modified Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) as assessed by Blinded Independent Central Review (BICR) or death due to any cause, whichever occurs first. rPFS in AR LBD mutation-positive participants will be reported for each study arm. |
Up to ~36 months
|
|
rPFS Per Prostate Cancer Working Group-modifiedRECIST 1.1 as Assessed by Blinded Independent Central Review in AR LBD Mutation-Negative Participants
大体时间:Up to ~36 months
|
rPFS is defined as the time from randomization to the first documented disease progression per Prostate Cancer Working Group (PCWG)-modified Response Evaluation Criteria in Solid Tumors Version 1.1 (RECIST 1.1) as assessed by Blinded Independent Central Review (BICR) or death due to any cause, whichever occurs first. rPFS in AR LBD mutation-positive participants will be reported for each study arm. |
Up to ~36 months
|
|
Time to Initiation of the First Subsequent Anti-Cancer Therapy or Death (TFST)
大体时间:Up to ~54 months
|
TFST is defined as the time from randomization to initiation of the first subsequent anticancer therapy or death, whichever occurs first. |
Up to ~54 months
|
|
Objective Response (OR)
大体时间:Up to ~54 months
|
OR is determined by PCWG-modified RECIST 1.1 as assessed by BICR. |
Up to ~54 months
|
|
Duration of Response (DOR)
大体时间:Up to ~54 months
|
DOR is determined by PCWG-modified RECIST 1.1 as assessed by BICR. |
Up to ~54 months
|
|
Time to Pain Progression (TTPP)
大体时间:Up to ~54 months
|
TTPP is assessed by Brief Pain Inventory-Short Form (BPI-SF) Item 3 ("Worst Pain in 24 Hours") and opiate analgesic use (Analgesic Quantification Algorithm [AQA] Score). |
Up to ~54 months
|
|
Time to Prostate-specific Antigen (PSA) Progression
大体时间:Up to ~54 months
|
The time from randomization to PSA progression. The PSA progression date is defined as the date of either: 1) ≥25% increase and ≥2 ng/mL above the nadir, confirmed by a second value ≥3 weeks later if there is PSA decline from baseline 2) ≥25% increase and ≥2 ng/mL increase from baseline beyond 12 weeks if there is no PSA decline from baseline. |
Up to ~54 months
|
|
Time to First Symptomatic Skeletal-related Event (SSRE)
大体时间:Up to ~54 months
|
The time from randomization to the first occurrence of any of the following symptomatic skeletal-related events: 1) Use of EBRT to prevent or relieve skeletal symptoms; 2) new symptomatic pathologic bone fracture (vertebral or non-vertebral); 3) spinal cord compression; or 4) tumor-related orthopedic surgical intervention. |
Up to ~54 months
|
|
Number of Participants Who Experience an Adverse Event
大体时间:Up to ~54 months
|
An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. |
Up to ~54 months
|
|
Number of Participants Who Discontinue Study Treatment Due to an Adverse Event
大体时间:Up to ~54 months
|
An AE is any untoward medical occurrence in a clinical study participant, temporally associated with the use of study intervention, whether or not considered related to the study intervention. |
Up to ~54 months
|
合作者和调查者
调查人员
- 研究主任:Medical Director、Merck Sharp & Dohme LLC
出版物和有用的链接
研究记录日期
研究主要日期
学习开始 (实际的)
初级完成 (估计的)
研究完成 (估计的)
研究注册日期
首次提交
首先提交符合 QC 标准的
首次发布 (实际的)
研究记录更新
最后更新发布 (实际的)
上次提交的符合 QC 标准的更新
最后验证
更多信息
与本研究相关的术语
其他相关的 MeSH 术语
其他研究编号
- 5684-003
- MK-5684-003 (其他标识符:MSD)
- jRCT2031240029 (注册表标识符:Japan Registry of Clinical Trials (jRCT))
- U1111-1287-5304 (注册表标识符:UTN)
- 2023-504899-25-00 (其他标识符:EU CT)
- 2023 (美国 NIH 拨款/合同)
计划个人参与者数据 (IPD)
计划共享个人参与者数据 (IPD)?
IPD 计划说明
https://trialstransparency.msdclinicaltrials.com/pdf/ProcedureAccessClinicalTrialData.pdf
药物和器械信息、研究文件
研究美国 FDA 监管的药品
研究美国 FDA 监管的设备产品
此信息直接从 clinicaltrials.gov 网站检索,没有任何更改。如果您有任何更改、删除或更新研究详细信息的请求,请联系 register@clinicaltrials.gov. clinicaltrials.gov 上实施更改,我们的网站上也会自动更新.